Answers are grounded in this paper and cite their sources.
Highlights the presentation of nonanesthesia-related malignant hyperthermia and the use of oral dantrolene for symptom control.
A 30-year-old man developed unexplained rhabdomyolysis, persistently increased creatine kinase and severe debilitating muscle cramps. After a nondiagnostic neurologic evaluation, he was referred for a muscle biopsy, to include histology/histochemistry, a myoglobinuria panel, and a caffeine halothane contracture test. Only the caffeine halothane contracture test was positive, and a subsequent ryanodine receptor type 1 gene evaluation revealed a mutation functionally causative for malignant hyperthermia. His identical twin brother, who was suffering from similar complaints, was found to share the same mutation. They each require oral dantrolene therapy to control symptoms, despite difficulty in identifying health care providers familiar with treating this disorder.
No takes yet. Share an insight, caveat, or question.
Potts et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: